Results
|
1.
|
|
|
2.
|
|
|
3.
|
Risk of cardiovascular adverse events from trastuzumab (Herceptin()) in elderly persons with breast cancer: a population-based study. MedStar authors:
Year: 2014
Citation: - Breast Cancer Research & Treatment. 144(1):163-70, 2014 Feb.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
All authors: - Barac A, Freedman AN, Fu AZ, Huang CY, Isaacs C, Potosky AL, Tsai HT, Warren JL
|
|
4.
|
Survival and secondary interventions following treatment for locally-advanced prostate cancer. MedStar authors:
- Carvalho, Filipe L F
- Harbin, Andrew
- Hwang, Jonathan J
- Kowalczyk, Kevin
- Stamatakis, Lambros
- Sussman, Rachael
Year: 2018
Citation: - Canadian Journal of Urology. 25(5):9516-9524, 2018 Oct.
Institution: - MedStar Washington Hospital Center
Department:
- Obstetrics and Gynecology/Female Pelvic Medicine and Reconstructive Surgery
- Urology
Medline publication type:
All authors: - Carvalho FLF, Harbin A, Hu JC, Hwang J, Kowalczyk KJ, Lynch JH, Stamatakis L, Sussman R, Williams SB, Zheng C
|
|
5.
|
Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma. MedStar authors:
Year: 2016
Citation: - Cancer. 122(1):124-30, 2016 Jan 1.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Atkins MB, Barac A, Freedman AN, Fu AZ, Jang S, Minasian L, Potosky AL, Tsai HT, Zheng C
|